These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21035975)

  • 1. Clinical immunogenicity specificity assessments: a platform evaluation.
    Peng K; Siradze K; Quarmby V; Fischer SK
    J Pharm Biomed Anal; 2011 Feb; 54(3):629-35. PubMed ID: 21035975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.
    Mikulskis A; Yeung D; Subramanyam M; Amaravadi L
    J Immunol Methods; 2011 Feb; 365(1-2):38-49. PubMed ID: 21130095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel homogeneous Biotin-digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum.
    Qiu ZJ; Ying Y; Fox M; Peng K; Lewin-Koh SC; Coleman D; Good J; Lowe J; Rahman A; Yang J; Jiang J; Quarmby V; Song A
    J Immunol Methods; 2010 Oct; 362(1-2):101-11. PubMed ID: 20868690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing specificity for immunogenicity assays.
    Swanson SJ; Chirmule N
    Bioanalysis; 2009 Jun; 1(3):611-7. PubMed ID: 21083156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assays.
    Kubiak RJ; Zhang L; Zhang J; Zhu Y; Lee N; Weichold FF; Yang H; Abraham V; Akufongwe PF; Hewitt L; Robinson S; Liu W; Liu X; Patnaik MM; Spitz S; Wu Y; Roskos LK
    J Pharm Biomed Anal; 2013 Feb; 74():235-45. PubMed ID: 23245256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry.
    Li J; Schantz A; Schwegler M; Shankar G
    J Pharm Biomed Anal; 2011 Jan; 54(2):286-94. PubMed ID: 20869832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of double antigen bridging immunoassay format on antigen coating concentration dependence and implications for designing immunogenicity assays for monoclonal antibodies.
    Bourdage JS; Lee TN; Taylor JM; Willey MB; Brandt JT; Konrad RJ
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):685-90. PubMed ID: 15927431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of analytical detection concepts to immunogenicity testing.
    Klakamp SL; Lu H; Tabrizi M; Funelas C; Roskos LK; Coleman D
    Anal Chem; 2007 Nov; 79(21):8176-84. PubMed ID: 17922557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug.
    Bourdage JS; Cook CA; Farrington DL; Chain JS; Konrad RJ
    J Immunol Methods; 2007 Oct; 327(1-2):10-7. PubMed ID: 17716682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore.
    Sickert D; Kroeger K; Zickler C; Chokote E; Winkler B; Grenet JM; Legay F; Zaar A
    J Immunol Methods; 2008 May; 334(1-2):29-36. PubMed ID: 18304570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity issues in drug development.
    Swanson SJ
    J Immunotoxicol; 2006 Sep; 3(3):165-72. PubMed ID: 18958697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA.
    Smith HW; Butterfield A; Sun D
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):230-7. PubMed ID: 17869396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming soluble target interference in an anti-therapeutic antibody screening assay for an antibody-drug conjugate therapeutic.
    Carrasco-Triguero M; Mahood C; Milojic-Blair M; Amaya C; Ruppel J; Hong K; Yi JH; Kaur S
    Bioanalysis; 2012 Aug; 4(16):2013-26. PubMed ID: 22946917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid factor interference in immunogenicity assays for human monoclonal antibody therapeutics.
    Tatarewicz S; Miller JM; Swanson SJ; Moxness MS
    J Immunol Methods; 2010 May; 357(1-2):10-6. PubMed ID: 20347831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirming human antibody responses to a therapeutic monoclonal antibody using a statistical approach.
    Neyer L; Hiller J; Gish K; Keller S; Caras I
    J Immunol Methods; 2006 Aug; 315(1-2):80-7. PubMed ID: 16935294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential reactivity of anti-primate and anti-human secondary antibodies against human and monkey immunoglobulins: implications for determining the sensitivity of immunogenicity assays.
    Bourdage JS; Brandt JT; Lee TN; Konrad RJ
    J Immunol Methods; 2005 Aug; 303(1-2):76-80. PubMed ID: 16033697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeutics.
    Finco D; Baltrukonis D; Clements-Egan A; Delaria K; Gunn GR; Lowe J; Maia M; Wong T
    J Pharm Biomed Anal; 2011 Jan; 54(2):351-8. PubMed ID: 20863644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for preclinical immunogenicity assessment of protein therapeutics.
    Stas P; Lasters I
    IDrugs; 2009 Mar; 12(3):169-73. PubMed ID: 19333897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HAHA--nothing to laugh about. Measuring the immunogenicity (human anti-human antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technology.
    Nechansky A
    J Pharm Biomed Anal; 2010 Jan; 51(1):252-4. PubMed ID: 19679421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of immuno-PCR technology platforms as an ultrasensitive tool for the detection of anti-drug antibodies.
    Jani D; Savino E; Goyal J
    Bioanalysis; 2015; 7(3):285-94. PubMed ID: 25697187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.